[Federal Register Volume 62, Number 198 (Tuesday, October 14, 1997)]
[Notices]
[Page 53343]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-27143]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By notice dated February 28, 1997, and published in the Federal 
Register on March 28, 1997, (62 FR 14944), Johnson & Johnson 
Pharmaceutical Partners, HC02 State Road 933, KMO.1 Makey Ward, HC-02 
Box 19250, Gurabo, Puerto Rico 00778-9629, made application by renewal 
to the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Sufentanil (9740), a basic class of controlled 
substance listed in Schedule II.
    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Johnson & 
Johnson Pharmaceutical to manufacturer sufentanil is consistent with 
the public interest at this time. Therefore, pursuant to 21 U.S.C. 823 
and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office 
of Diversion Control, hereby orders that the application submitted by 
the above firm for registration as a bulk manufacturer of the basic 
class of controlled substance listed above is granted.

    Dated: October 1, 1997.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 97-27143 Filed 10-10-97; 8:45 am]
BILLING CODE 4410-09-M